Policy Community, Policy Network and Comparative Industrial Policies

This article explores ways in which the relationships between 'government' and 'industry' in the making and carrying out of policy can be compared cross-sectorally and cross-nationally. It draws attention to the accumulating empirical evidence which suggests a disjuncture between conventional characterizations of national economic and industrial policies and processes, with what actually happens in practice. It argues that more systematic attention needs to be given to the analysis of the norms of policy and behaviour at different policy levels. Using the concepts of policy community and policy network, it shows how policy networks can be identified, characterized and compared, and how relationships within networks are regulated by 'rules of the game'.     

Who Governs Japan? Politicians and Bureaucrats in the Policy-making Processes

The long-running debate about who governs Japan has been given a new twist by 'rat-choicers' who argue that Japan has been governed for the last thirty years or more neither by bureaucrats nor by a 'conservative coalition' of bureaucrats, politicians and businessmen but by the Liberal Democratic Party alone. This article examines their arguments and sets them in the context of other competing and conflicting explanations. It is argued that more relevant and researchable questions are what is governed and how, an approach calling for a more nuanced analysis of policy making in order to observe the impact on different policies and policy-processes of the role of the state and its institutional structures and their embedded 'collective identities'.     

Advanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far?

This Regulation seeks to regulate existing and future advancedtherapy medicinal products intended for the market in MemberStates, being either prepared industrially or manufactured bya method involving an industrial process, and introduces additionalprovisions to those laid down in the pharmaceutical legislationDirective 2001/83.